BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19897031)

  • 1. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.
    Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
    Biochim Biophys Acta; 2010 Feb; 1802(2):292-300. PubMed ID: 19897031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.
    Visser M; Palstra RJ; Kayser M
    Hum Mol Genet; 2015 May; 24(9):2649-61. PubMed ID: 25631878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.
    Morrison BA; Ucisik-Akkaya E; Flores H; Alaez C; Gorodezky C; Dorak MT
    Autoimmunity; 2010 Dec; 43(8):690-7. PubMed ID: 21067287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia.
    Dorak MT; Lawson T; Machulla HK; Darke C; Mills KI; Burnett AK
    Blood; 1999 Jul; 94(2):694-700. PubMed ID: 10397736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
    Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
    Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression.
    Cao Y; Li H; Sun Y; Chen X; Liu H; Gao X; Liu X
    Eur J Immunol; 2010 Nov; 40(11):3198-209. PubMed ID: 21061442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood.
    Adamaki M; Lambrou GI; Athanasiadou A; Tzanoudaki M; Vlahopoulos S; Moschovi M
    PLoS One; 2013; 8(8):e72326. PubMed ID: 23977280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of interferon regulatory factor 4 (IRF4) in immune cell development.
    Nam S; Lim JS
    Arch Pharm Res; 2016 Nov; 39(11):1548-1555. PubMed ID: 27826752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA complex-linked heat shock protein genes and childhood acute lymphoblastic leukemia susceptibility.
    Ucisik-Akkaya E; Davis CF; Gorodezky C; Alaez C; Dorak MT
    Cell Stress Chaperones; 2010 Sep; 15(5):475-85. PubMed ID: 20012387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia.
    Dorak MT; Owen G; Galbraith I; Henderson N; Webb D; Mills KI; Darke C; Burnett AK
    Leukemia; 1995 May; 9(5):875-8. PubMed ID: 7769851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the Correlation Between Interleukin-6 Promoter Polymorphism -174G/C and Interferon Regulatory Factor 4 rs12203592 Polymorphism With Skin Cancer Susceptibility.
    Wu M; Cao Y; Liu YL; Ma LL; Yang XH
    Am J Ther; 2016; 23(6):e1758-e1767. PubMed ID: 26928068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells.
    Chhabra Y; Yong HXL; Fane ME; Soogrim A; Lim W; Mahiuddin DN; Kim RSQ; Ashcroft M; Beatson SA; Ainger SA; Smit DJ; Jagirdar K; Walker GJ; Sturm RA; Smith AG
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):51-63. PubMed ID: 28755520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.
    Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R
    J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
    Boddicker RL; Kip NS; Xing X; Zeng Y; Yang ZZ; Lee JH; Almada LL; Elsawa SF; Knudson RA; Law ME; Ketterling RP; Cunningham JM; Wu Y; Maurer MJ; O'Byrne MM; Cerhan JR; Slager SL; Link BK; Porcher JC; Grote DM; Jelinek DF; Dogan A; Ansell SM; Fernandez-Zapico ME; Feldman AL
    Blood; 2015 May; 125(20):3118-27. PubMed ID: 25833963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focused screening of a panel of cancer-related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia.
    Offenmüller S; Ravindranath Y; Goyette G; Kanakapalli D; Miller KS; Brecht IB; Zolk O
    Pediatr Blood Cancer; 2014 Aug; 61(8):1411-5. PubMed ID: 24604828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF4 rs12203592 functional variant and melanoma survival.
    Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
    Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.
    Slager SL; Achenbach SJ; Asmann YW; Camp NJ; Rabe KG; Goldin LR; Call TG; Shanafelt TD; Kay NE; Cunningham JM; Wang AH; Weinberg JB; Norman AD; Link BK; Leis JF; Vachon CM; Lanasa MC; Caporaso NE; Novak AJ; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):461-6. PubMed ID: 23307532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.
    Butrym A; Łacina P; Rybka J; Chaszczewska-Markowska M; Mazur G; Bogunia-Kubik K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):151-156. PubMed ID: 28083618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility.
    Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
    Cancer Genet Cytogenet; 2009 Nov; 195(1):31-6. PubMed ID: 19837266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.